ACO Models
Expert articles and analysis related to aco models.
AI Summary — Last 7 Days
ACO policy attention this week centered on reducing administrative friction while organizations make high-stakes model selection decisions: the House passed legislation to ease Medicare ACO digital quality reporting requirements, a move backed by NAACOS as relief from infrastructure-heavy eCQM/MIPS CQM reporting mandates that many ACOs view as misaligned with VBC participation economics (AJMC). At the same time, LEAD acceptance letters are out, Participant TIN lists are due to CMS in early August, and applicants overlapping with MSSP now face a near-term choice before final rules and LEAD’s financial methodology are fully known—heightening downside-risk, benchmarking, and participant-composition strategy questions for ACO operators (Wakely). The broader pattern is a Trump administration-era VBC environment in which CMS model expansion and congressional reporting relief are moving in parallel, but ACOs still face uncertainty around risk adjustment, data infrastructure, and whether new model economics will justify the operational lift.
Related Articles
House Passes Bill to Ease Quality Reporting Requirements for Medicare ACOs
House Passes Bill to Ease Quality Reporting Requirements for Medicare ACOs MedPage Today
Revised Model Legislation: An Act to Reduce Prescription Drug Costs Using Medicare Maximum Fair Price (MFP) Reference-Based Pricing
View NASHP’s updated model legislation using Medicare maximum fair prices as upper payment limits with savings validation and public comment. The post Revised Model Legislation: An Act to Reduce Presc...
Q&A: Revised Model Legislation: An Act to Reduce Prescription Drug Costs Using Medicare Maximum Fair Price Reference-Based Pricing
Learn how this model act uses Medicare's negotiated drug prices as reference rates to help states reduce prescription drug costs. The post Q&A: Revised Model Legislation: An Act to Reduce Prescription...
Pharmaceutical Manufacturer response to Most Favored Nation (MFN): Delay, Hide or Confuse?
Today I attended the very interesting ISPOR Health Policy Leadership Exchange (HPLE) in Washington DC on the topic of Most Favored Nation (MFN). There were a number of important points made and I’ll s...
House Passes Bill to Ease Medicare ACO Digital Quality Reporting Burden
House Passes Bill to Ease Medicare ACO Digital Quality Reporting Burden AJMC
House Passes Bill to Ease Medicare ACO Digital Quality Reporting Burden
Accepted into LEAD – Now What? ACO Risk Mitigation Strategies Part 2
LEAD acceptance letters are out, the Participant TIN list is due to CMS in early August, and the financial methodology that governs how shared savings and payments work is expected later this summer. ...
Extending Medicare Maximum Fair Prices for Drugs to State Markets
NASHP’s updated model legislation helps states use Medicare drug prices as reimbursement caps to lower commercial drug costs. The post Extending Medicare Maximum Fair Prices for Drugs to State Markets...
Statement: NAACOS Applauds Congress’ New Progress on Reducing ACO Reporting Burden - National Association of ACOs (NAACOS)
Statement: NAACOS Applauds Congress’ New Progress on Reducing ACO Reporting Burden National Association of ACOs (NAACOS)
Medicare Drug Price Negotiation Program Proposed Rule Summary
HFMA provides a detailed summary of the proposed rule to codify the Medicare Drug Price Negotiation Program (“Negotiation Program”) and establish certain new policies for the Negotiation Program and t...